Scholars examine the pace and potential impact of President Trump’s first 100 days.

Experts reflect on a new book assessing Presidents’ impact on regulatory priorities and successes.

Reinvigorating nondelegation requires not just a reformulation of the doctrine, but also a willingness to apply it.

Scholar proposes reforms to address deficiencies in FDA’s premarket review powers.

Scholars propose changes to patent disclosures under the Biologics Price Competition and Innovation Act.

The Regulatory Review extends its gratitude to the publication’s graduating leadership and team members.

President Trump issues orders to limit criminal regulatory offenses and lower prescription drug costs, and more…

Executive orders to repeal rules and redefine “showerhead” contain a jarring assertion of presidential authority.

Scholar urges lawmakers to hold multi-level marketing companies liable for misleading claims made by salespeople.